General Information of Drug Transporter (DT)
DT ID DTD0102 Transporter Info
Gene Name SLC16A11
Transporter Name Monocarboxylate transporter 11
Gene ID
162515
UniProt ID
Q8NCK7
Epigenetic Regulations of This DT (EGR)

Methylation

  Colon cancer

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 1.84E-03; Z-score: -1.25E+00

Methylation in Case

9.45E-02 (Median) Methylation in Control 1.17E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

TSS200 (cg04913974)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 2.37E-04; Z-score: -2.50E+00

Methylation in Case

4.50E-01 (Median) Methylation in Control 5.56E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

1stExon (cg26923754)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 3.43E-03; Z-score: -9.57E-01

Methylation in Case

5.05E-01 (Median) Methylation in Control 5.37E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

Body (cg04569615)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 1.13E-03; Z-score: 9.77E-01

Methylation in Case

6.93E-01 (Median) Methylation in Control 6.11E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

Body (cg19130824)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 1.40E-03; Z-score: 7.47E-01

Methylation in Case

7.77E-01 (Median) Methylation in Control 7.46E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

Body (cg14808360)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 3.66E-03; Z-score: 8.33E-01

Methylation in Case

9.04E-01 (Median) Methylation in Control 8.87E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in colon adenocarcinoma [ 1 ]

Location

3'UTR (cg00630480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 1.99E-03; Z-score: -1.63E+00

Methylation in Case

5.73E-01 (Median) Methylation in Control 6.48E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Bladder cancer

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

TSS1500 (cg21090344)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.03E+00 Statistic Test p-value: 8.38E-09; Z-score: -8.53E+00

Methylation in Case

1.69E-01 (Median) Methylation in Control 5.12E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

TSS1500 (cg14950751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 2.58E-05; Z-score: -3.68E+00

Methylation in Case

2.29E-01 (Median) Methylation in Control 3.37E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

TSS1500 (cg16374411)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 7.47E-04; Z-score: -3.92E+00

Methylation in Case

1.83E-01 (Median) Methylation in Control 2.70E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

TSS200 (cg13181928)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.48E+00 Statistic Test p-value: 2.91E-03; Z-score: -2.72E+00

Methylation in Case

1.12E-01 (Median) Methylation in Control 1.66E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

TSS200 (cg07011163)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.22E+00 Statistic Test p-value: 2.93E-02; Z-score: -1.28E+00

Methylation in Case

1.09E-01 (Median) Methylation in Control 1.33E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

TSS200 (cg03892045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.75E+00 Statistic Test p-value: 4.01E-02; Z-score: -1.66E+00

Methylation in Case

5.71E-02 (Median) Methylation in Control 1.00E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

Body (cg05031424)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.29E+00 Statistic Test p-value: 1.13E-05; Z-score: -3.21E+00

Methylation in Case

5.02E-01 (Median) Methylation in Control 6.50E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

Body (cg03096732)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.44E+00 Statistic Test p-value: 2.31E-05; Z-score: -4.23E+00

Methylation in Case

1.19E-01 (Median) Methylation in Control 1.71E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC16A11 in bladder cancer [ 2 ]

Location

Body (cg18736141)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.53E+00 Statistic Test p-value: 5.70E-03; Z-score: -2.23E+00

Methylation in Case

1.18E-01 (Median) Methylation in Control 1.81E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS1500 (cg21090344)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 1.87E-03; Z-score: -5.87E-01

Methylation in Case

5.76E-01 (Median) Methylation in Control 6.29E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS1500 (cg16374411)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 1.33E-02; Z-score: 9.06E-01

Methylation in Case

2.96E-01 (Median) Methylation in Control 2.68E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS200 (cg07011163)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 5.08E-06; Z-score: 2.04E+00

Methylation in Case

1.42E-01 (Median) Methylation in Control 9.97E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS200 (cg13181928)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.45E+00 Statistic Test p-value: 1.16E-05; Z-score: 1.99E+00

Methylation in Case

1.68E-01 (Median) Methylation in Control 1.16E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS200 (cg03892045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.44E+00 Statistic Test p-value: 8.00E-05; Z-score: 1.21E+00

Methylation in Case

8.67E-02 (Median) Methylation in Control 6.01E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS200 (cg08352268)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.18E+00 Statistic Test p-value: 1.77E-03; Z-score: 8.79E-01

Methylation in Case

1.13E-01 (Median) Methylation in Control 9.58E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS200 (cg03712541)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.41E+00 Statistic Test p-value: 3.75E-03; Z-score: 5.92E-01

Methylation in Case

5.01E-02 (Median) Methylation in Control 3.54E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

TSS200 (cg18530716)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.18E+00 Statistic Test p-value: 7.36E-03; Z-score: 5.81E-01

Methylation in Case

1.00E-01 (Median) Methylation in Control 8.49E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

Body (cg02489908)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 1.76E-06; Z-score: 1.97E+00

Methylation in Case

3.54E-01 (Median) Methylation in Control 2.92E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

Body (cg18736141)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 1.05E-03; Z-score: 6.15E-01

Methylation in Case

2.04E-01 (Median) Methylation in Control 1.83E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

Body (cg01019875)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 3.23E-02; Z-score: 1.61E-01

Methylation in Case

1.80E-01 (Median) Methylation in Control 1.72E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

Body (cg03096732)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 3.83E-02; Z-score: -1.36E+00

Methylation in Case

1.40E-01 (Median) Methylation in Control 1.70E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC16A11 in breast cancer [ 3 ]

Location

Body (cg19639560)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 3.93E-02; Z-score: 2.44E-01

Methylation in Case

5.55E-01 (Median) Methylation in Control 5.31E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS1500 (cg16374411)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 1.42E-03; Z-score: 7.24E-01

Methylation in Case

3.57E-01 (Median) Methylation in Control 3.17E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS1500 (cg14950751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 2.77E-03; Z-score: 6.82E-01

Methylation in Case

2.58E-01 (Median) Methylation in Control 2.20E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS200 (cg07011163)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 2.28E-04; Z-score: 9.62E-01

Methylation in Case

1.93E-01 (Median) Methylation in Control 1.67E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS200 (cg13181928)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.15E+00 Statistic Test p-value: 4.23E-04; Z-score: 1.01E+00

Methylation in Case

2.23E-01 (Median) Methylation in Control 1.94E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS200 (cg03892045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.23E+00 Statistic Test p-value: 6.17E-03; Z-score: 8.41E-01

Methylation in Case

5.59E-02 (Median) Methylation in Control 4.55E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS200 (cg18530716)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 1.20E-02; Z-score: 5.93E-01

Methylation in Case

2.05E-01 (Median) Methylation in Control 1.77E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

TSS200 (cg03712541)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 1.71E-02; Z-score: 5.49E-01

Methylation in Case

3.15E-02 (Median) Methylation in Control 2.35E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC16A11 in colorectal cancer [ 4 ]

Location

Body (cg05031424)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 5.53E-10; Z-score: -2.33E+00

Methylation in Case

8.07E-01 (Median) Methylation in Control 8.85E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg21090344)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 5.41E-04; Z-score: -7.66E-01

Methylation in Case

4.15E-01 (Median) Methylation in Control 4.97E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg14950751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 2.51E-02; Z-score: -7.25E-01

Methylation in Case

2.89E-01 (Median) Methylation in Control 3.38E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

TSS200 (cg13167631)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.18E+00 Statistic Test p-value: 2.00E-15; Z-score: -2.20E+00

Methylation in Case

2.44E-01 (Median) Methylation in Control 5.33E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

Body (cg03816707)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.38E+00 Statistic Test p-value: 7.29E-24; Z-score: 4.51E+00

Methylation in Case

5.10E-01 (Median) Methylation in Control 2.14E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

Body (cg21227867)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.52E+00 Statistic Test p-value: 3.21E-19; Z-score: -4.47E+00

Methylation in Case

4.83E-01 (Median) Methylation in Control 7.34E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

Body (cg18736141)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.51E+00 Statistic Test p-value: 1.91E-07; Z-score: -1.75E+00

Methylation in Case

1.74E-01 (Median) Methylation in Control 2.61E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

Body (cg02489908)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.58E+00 Statistic Test p-value: 2.97E-07; Z-score: -1.94E+00

Methylation in Case

1.98E-01 (Median) Methylation in Control 3.14E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

Body (cg19639560)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.38E+00 Statistic Test p-value: 3.12E-07; Z-score: -1.18E+00

Methylation in Case

3.92E-01 (Median) Methylation in Control 5.39E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC16A11 in hepatocellular carcinoma [ 5 ]

Location

Body (cg05031424)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 7.35E-05; Z-score: -8.11E-01

Methylation in Case

5.41E-01 (Median) Methylation in Control 6.30E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in lung adenocarcinoma [ 6 ]

Location

TSS1500 (cg16374411)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 1.33E-03; Z-score: -1.85E+00

Methylation in Case

3.63E-01 (Median) Methylation in Control 4.39E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in lung adenocarcinoma [ 6 ]

Location

TSS1500 (cg14950751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.30E+00 Statistic Test p-value: 2.95E-03; Z-score: -2.66E+00

Methylation in Case

3.45E-01 (Median) Methylation in Control 4.48E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in lung adenocarcinoma [ 6 ]

Location

TSS200 (cg13181928)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 9.35E-03; Z-score: -1.55E+00

Methylation in Case

2.50E-01 (Median) Methylation in Control 3.32E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg01532168)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.53E+00 Statistic Test p-value: 1.02E-12; Z-score: 2.73E+00

Methylation in Case

4.49E-01 (Median) Methylation in Control 1.27E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg17445913)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 2.90E-09; Z-score: 4.49E-01

Methylation in Case

1.82E-01 (Median) Methylation in Control 1.69E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg27435138)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 3.09E-03; Z-score: 7.39E-01

Methylation in Case

8.01E-01 (Median) Methylation in Control 7.45E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg11699666)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 1.36E-02; Z-score: 6.02E-01

Methylation in Case

5.87E-02 (Median) Methylation in Control 5.14E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS200 (cg24751648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.27E+00 Statistic Test p-value: 1.55E-04; Z-score: -1.01E+00

Methylation in Case

1.21E-01 (Median) Methylation in Control 1.54E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS200 (cg02780017)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 6.09E-04; Z-score: -9.65E-01

Methylation in Case

5.44E-01 (Median) Methylation in Control 6.81E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg26426186)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 4.47E-07; Z-score: -6.73E-01

Methylation in Case

7.66E-01 (Median) Methylation in Control 7.83E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg09945896)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 6.80E-05; Z-score: -7.78E-01

Methylation in Case

7.63E-01 (Median) Methylation in Control 7.87E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg18104539)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.69E-04; Z-score: -6.98E-01

Methylation in Case

9.00E-01 (Median) Methylation in Control 9.08E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg04794858)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 1.39E-03; Z-score: 1.16E+00

Methylation in Case

8.55E-01 (Median) Methylation in Control 8.16E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg08799967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 1.68E-02; Z-score: 7.13E-01

Methylation in Case

8.03E-01 (Median) Methylation in Control 7.71E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg05369268)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.06E+00 Statistic Test p-value: 1.76E-02; Z-score: 6.29E-01

Methylation in Case

9.25E-01 (Median) Methylation in Control 8.71E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC16A11 in pancretic ductal adenocarcinoma [ 7 ]

Location

3'UTR (cg05868813)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.29E+00 Statistic Test p-value: 3.02E-10; Z-score: -1.95E+00

Methylation in Case

5.68E-01 (Median) Methylation in Control 7.35E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Panic disorder

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in panic disorder [ 8 ]

Location

TSS1500 (cg14950751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.02E-01 Statistic Test p-value: 1.30E-03; Z-score: -4.59E-01

Methylation in Case

-1.94E+00 (Median) Methylation in Control -1.75E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in panic disorder [ 8 ]

Location

TSS200 (cg03892045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.68E-01 Statistic Test p-value: 2.69E-02; Z-score: -2.43E-01

Methylation in Case

-4.85E+00 (Median) Methylation in Control -4.69E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in panic disorder [ 8 ]

Location

Body (cg01019875)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -8.93E-01 Statistic Test p-value: 2.77E-02; Z-score: -5.76E-01

Methylation in Case

-4.96E+00 (Median) Methylation in Control -4.42E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Celiac disease

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in celiac disease [ 9 ]

Location

TSS200 (cg13181928)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.02E+00 Statistic Test p-value: 4.73E-02; Z-score: 1.27E+00

Methylation in Case

8.13E-02 (Median) Methylation in Control 2.69E-02 (Median)

Studied Phenotype

Celiac disease [ ICD-11: DA95]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

TSS200 (cg07011163)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 7.39E-03; Z-score: 5.81E-01

Methylation in Case

2.26E-01 (Median) Methylation in Control 1.85E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

TSS200 (cg13181928)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.63E+00 Statistic Test p-value: 9.31E-03; Z-score: 2.32E+00

Methylation in Case

4.18E-01 (Median) Methylation in Control 2.56E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

TSS200 (cg03712541)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 1.20E-02; Z-score: -1.43E-01

Methylation in Case

5.28E-02 (Median) Methylation in Control 5.90E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

TSS200 (cg08352268)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 2.32E-02; Z-score: 1.43E-01

Methylation in Case

9.97E-02 (Median) Methylation in Control 9.36E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

Body (cg02489908)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 1.25E-03; Z-score: 1.46E+00

Methylation in Case

3.23E-01 (Median) Methylation in Control 2.79E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

Body (cg18736141)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.28E-02; Z-score: 4.71E-01

Methylation in Case

1.39E-01 (Median) Methylation in Control 1.16E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC16A11 in clear cell renal cell carcinoma [ 10 ]

Location

Body (cg05031424)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 2.56E-02; Z-score: -6.76E-01

Methylation in Case

7.02E-01 (Median) Methylation in Control 7.34E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC16A11 in papillary thyroid cancer [ 11 ]

Location

Body (cg05031424)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.43E-05; Z-score: -9.34E-01

Methylation in Case

8.41E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC16A11 in papillary thyroid cancer [ 11 ]

Location

Body (cg02489908)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 4.41E-05; Z-score: 1.21E+00

Methylation in Case

3.28E-01 (Median) Methylation in Control 2.82E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC16A11 in papillary thyroid cancer [ 11 ]

Location

Body (cg03096732)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 3.82E-03; Z-score: -8.50E-01

Methylation in Case

1.64E-01 (Median) Methylation in Control 2.03E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC16A11 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 5.33E-09; Fold-change: 0.407605361; Z-score: 5.731705893
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
References
1 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
6 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
7 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
8 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
9 The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
10 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
11 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.